Home
Categories
DMD
Research
Press Releases
Approved Treatments
Editorials
Family Stories
Cures
WhatsApp Channel
About Us
Contact
Search
Home
Categories
DMD
Research
Press Releases
Approved Treatments
Editorials
Family Stories
Cures
WhatsApp Channel
About Us
Contact
More
Search
Home
Tags
Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy
Research
ImmunoForge Receives FDA IND Approval for Phase 2 Clinical Trial of ‘Pemziviptadil’ for DMD Cardiomyopathy
Press Releases
Sarepta Reiterated Total Net Product Revenue of $3.0 Billion in 2025
Press Releases
Wave Life Sciences Announces Plans for Exon 53 Skipping Study in 2025
Press Releases
Edgewise Therapeutics Announces Plans for 2025
DMD
Nutrition Guideline for Duchenne Muscular Dystrophy: Foods to Eat and Avoid
Press Releases
Plans for DYNE-101 in DM1 and DYNE-251 in DMD Are Announced by Dyne Therapeutics
Research
What is Ataluren (Translarna)? What is Ataluren Used For?
Press Releases
Avidity Biosciences Prepares for Three Rare Muscle Disease Programs’ 2025 BLA Submission and Commercialization
Press Releases
Percheron Disappointed in Avicursen (ATL1102) Study For Duchenne (DMD)
1
...
3
4
5
Page 4 of 5
Popular
Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy
DMD Warrior
-
December 26, 2024
Must Read
DMD
Micro Dystrophin: 5 Critical Questions Everyone Is Thinking About
Press Releases
SonoThera Ultrasound-Mediated Delivery Method Can Deliver Full-Length Dystrophin to Cells
Press Releases
Scribe Therapeutics and Prevail Therapeutics to Share In Vivo CRISPR-based Genome Editing Data at ASGCT 2025